A collaboration between biopharmaceutical maker Gilead Sciences and biotechnology company Goldfinch Bio aims to develop precision medicines for treating various kidney diseases. . . . → Read More: Companies Partner on Kidney Disease in $2B Deal
|
|||||
|
|
A new biotechnology enterprise plans to apply genetic analysis and the gene-editing technology Crispr to reduce the risk of coronary artery disease. . . . → Read More: Start-Up to Use Crispr for Heart Disease, Gains $59M 
An experimental treatment using a person’s modified T-cells from the immune system to attack solid tumor cancers received a U.S. patent. . . . → Read More: Patent Awarded for Engineered T-Cell Cancer Therapy  One comment - (Comments are closed)  Intellectual property  biomedical, biotechnology, cancer, licensing, life sciences, patent, pharmaceuticals, USPTO 
A new company provides a service that determines a person’s condition for disease treatments based on indicators derived from an analysis of huge medical-image databases. . . . → Read More: Start-Up Analyzes Images to Determine Medical Condition Comments are closed Intellectual property, New products biomarkers, biomedical, engineering, entrepreneurs, licensing, life sciences, mathematics, medical device, physical sciences, software, university 
Two biotechnology companies plan to develop new therapies mainly for eye and neurological diseases that silence genes responsible for those conditions. . . . → Read More: Biotechs Partner on Gene Silencing in $1.1B Deal Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, equity, genomics, investment, licensing, life sciences, pharmaceuticals 
Two biotechnology enterprises working in genome editing and regenerative medicine are sharing their technologies to develop off-the-shelf cell therapies. . . . → Read More: Biotechs Join Forces for Off-the-Shelf Stem Cells One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, clinical trials, entrepreneurs, genomics, licensing, life sciences, pharmaceuticals, preclinical, university 
A new company is licensing technology from the lab of its co-founder at Harvard University to develop stem cell therapies for any recipients, without causing immune reactions. . . . → Read More: Start-Up Creating Off-the-Shelf Stem Cell Therapies One comment - (Comments are closed) Intellectual property, New products biomedical, biotechnology, entrepreneurs, equity, genomics, investment, licensing, life sciences, pharmaceuticals, stem cells, university, venture capital 
Sherlock Biosciences Inc., a new enterprise offering medical diagnostics based on the genome-editing technology Crispr, is starting up with $35 million in seed financing. . . . → Read More: Crispr Diagnostics Company Launches with $35M Funding Comments are closed Intellectual property, New products biomedical, biotechnology, engineering, entrepreneurs, genomics, investment, licensing, life sciences, medical device, university 
A company based on university lab research in the U.K. says it’s producing graphene, a promising carbon-based material, in quality and scale for electronics. . . . → Read More: Spin-Off Producing Commercial-Grade Graphene One comment - (Comments are closed) Intellectual property, New products computer science, energy, engineering, entrepreneurs, licensing, manufacturing, materials science, physical sciences, physics, semiconductors, U.K., university 
A start-up company spun off from Purdue University is developing a system that translates visual images to touch-sensing signals for people with limited visual abilities. . . . → Read More: Start-Up Creating Touch Sensing for Visual Images Comments are closed Intellectual property, New products biomedical, computer science, engineering, entrepreneurs, licensing, life sciences, mathematics, NSF, patent, physical sciences, software, university |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||